Hi Bean,
When a Co 's portfolio remains unrealized its difficault to put a number on it.....And then we have the Merger thrown into this along with possible other avenues ......
As recently pointed out by another poster ....there is a big question here as to what the value of Libigel, Bio T , Elestrin, Pill plus all left out of the Co's evaluation !
So we have a potential partner in ANI ......But for a small part of Bpax portfolio lol
Your gusss is as good as mine JMHO
being included in the ANi merger? and provided in the
Market Data 
Markets 
AI
